HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2- (2- (5- bromo- 1H- indol- 3- yl)ethyl)- 3- (1- methylethoxyphenyl)- 4- (3H)- quinazolinone

CCK2 receptor antagonist

Also Known As:

LY 225910; LY225910

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinazolines: 402
      - Quinazolinones: 124
        2-(2-(5-bromo-1H-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3H)-quinazolinone: 1

Related Diseases

1.	Wounds and Injuries (Trauma) 12/16/2022 - "Proglumide accelerated the recovery of normal sensitivity, while Ly225910 totally prevented the onset of allodynia and nerve injuries induced by VCR. "
2.	Neoplasms (Cancer) 12/16/2022 - "Immunofluorescence and morphological analyses were performed on the skin, DRG and sciatic nerve at day 7. The cytotoxicity of VCR in combination with proglumide/Ly225910 was evaluated in human cancer cell lines. "
3.	Hyperalgesia 12/16/2022 - "Proglumide accelerated the recovery of normal sensitivity, while Ly225910 totally prevented the onset of allodynia and nerve injuries induced by VCR. "

Related Drugs and Biologics

1.	Proglumide (Milid)